JAKARTA (Yosefadi) – State pharmaceutical company PT Kimia Farma Tbk (KAEF) booked net profit of Rp145 billion in first nine months of 2014, grew by 18.9 from Rp122 billion in the same period of 2013.
Net sales increased 9.3% to Rp3.08 trillion from previous Rp2.82 trillion. While operating profit jumped 25.9% to Rp214 billion. Operating profit margin increased 15.2% to 7% and net profit margin was up 8.9% to 4.7%.
| Kimia Farma (KAEF) | 30-Sep-14 | 31-Dec-13 | Change (%) |
| BALANCE SHEET | |||
| Assets | 4,599 | 4,282 | 7.4 |
| Current | 1,857 | 1,810 | 2.6 |
| Non Current | 2,742 | 2,472 | 10.9 |
| Liabilities | 1,028 | 847 | 21.3 |
| Current | 912 | 746 | 22.2 |
| Long Term | 116 | 101 | 14.9 |
| Equity | 1,714 | 1,624 | 5.5 |
| Shares Volume | 5,554 | 5,554 | 0.0 |
| PROFIT-LOSS | 9M/14 | 9M/13 | Change (%) |
| Net Sales | 3,078 | 2,816 | 9.3 |
| Operating Profit | 214 | 170 | 25.9 |
| Net Profit | 145 | 122 | 18.9 |
| Profit Attributable to Equity | 144 | 121 | 19.0 |
| EPS | 26 | 22 | 18.4 |
| in billion Rp, EPS in Rp, shares volume in million | |||
| Stock & Market Cap | Value | Gap (%) | |
| Bottom (Rp) | 480 | 126.0 | |
| Peak (Rp) | 1,370 | -20.8 | |
| 30-Dec-13 (Rp) | 520 | 108.7 | |
| Current Price (Rp) | 1,085 | ||
| Mkt Cap (billion Rp) | 6,026 | ||
| Mkt Cap/Assets (X) | 1.3 | ||
| PER (X) | 20.9 | ||
| PBV (X) | 3.5 | ||
| Ratios (%) | 9M/14 | 9M/13 | Change |
| Liabilities to Equity | 60.0 | 52.2 | 15.0 |
| Current Ratio | 203.7 | 242.6 | -16.0 |
| ROA | 6.3 | 5.7 | 10.8 |
| ROE | 16.8 | 14.9 | 12.8 |
| OPM | 7.0 | 6.0 | 15.2 |
| NPM | 4.7 | 4.3 | 8.9 |